FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 2180612 · Received July 27, 2011

Report

Report Number
6000001-2011-15077
Event Type
Malfunction
Date Received
July 27, 2011
Date of Event
July 9, 2011
Report Date
July 11, 2011
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
PMA / PMN Number
K041738
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED. THE REPORTER INITIALLY REPORTED THAT THE SAMPLE IS AVAILABLE. HOWEVER, THE SAMPLE WAS NEVER RETURNED TO BAXTER. THEREFORE, THE DEVICE WAS NOT EVALUATED, THE REPORTED CONDITION COULD NOT BE CONFIRMED, AND NO ROOT CAUSE WAS IDENTIFIED.

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE IS AVAILABLE FOR EVALUATION PER THE CUSTOMER; HOWEVER, THE DEVICE HAS NOT YET BEEN RECEIVED BY BAXTER. SHOULD THE DEVICE BE RECEIVED BY BAXTER FOR EVALUATION, A FOLLOW-UP REPORT WILL BE FILED UPON COMPLETION OF AN EVALUATION OR IF ANY ADDITIONAL INFORMATION BECOMES AVAILABLE. PER REVIEW OF THE BATCH RECORDS, NO NONCONFORMANCE REPORT WAS DOCUMENTED FOR THIS LOT. ALL RELEASE CRITERIA WERE MET FOR THE BUILD OF THE LOT.

Description of Event or Problem · 1

BAXTER (B)(4) RECEIVED A REPORT THAT AN INFUSOR HAD DELIVERY STOP AND BLOOD BACKFLOW DURING PATIENT USE. THE CONCOMITANT MEDICAL PRODUCTS ARE CURRENTLY UNKNOWN. THIS CONDITION INTERRUPTED THERAPY. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO REPORT OF PATIENT INJURY, MEDICAL INTERVENTION NECESSARY, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. THE SAMPLE IS AVAILABLE. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 10N047

Patients

Seq Age Sex Outcome Treatment
1